Graft-versus-myeloma after donor leukocyte infusion: Maintenance of marrow remission but extramedullary relapse with plasmacytomas

Bone Marrow Transplantation

Volumn 21, Issue 11, 1998, Pages 1163-1165

  Zomas, A ^a   Stefanoudaki, K ^a   Fisfis, M ^a   Papadaki, T ^b   Mehta, J ^c  

^a St Anargyri General Cancer Hospital   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Extramedullary plasmacytoma; Graft versus host disease; Graft versus myeloma; Immunotherapy; Multiple myeloma

Indexed keywords

ALPHA INTERFERON; CD3 ANTIGEN; CD34 ANTIGEN; CISPLATIN; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; IMMUNOSUPPRESSIVE AGENT;

ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CASE REPORT; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE TRANSFUSION; MALE; MONONUCLEAR CELL; MULTIPLE MYELOMA; PLASMACYTOMA; PRIORITY JOURNAL; RELAPSE;

EID: 0031831877     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701236     Document Type: Article

References (18)

1. Bjorkstrand B, Ljungman P, Bird JM et al. Autologous stem cell transplantation in multiple myeloma: results of the European Group for Bone Marrow Transplantation. Stem Cells 1995; 13 (Suppl. 2): 140-146.
2. Gahrton G, Tura S, Ljungman P et al. Prognostic factors in allogeneic bone marrow transplantation for multiple myeloma. J Clin Oncol 1995; 13: 1312-1322.
3. Mehta J. The graft-versus-myeloma effect. In: Barrett AJ, Jiang YZ (eds). The Graft Versus Leukemia Effect in Allogeneic Stem Cell Transplantation. Marcel Dekker: New York, 1998 (in press).
4. Tricot G, Vesole DH, Jagannah S et al. Graft-versus-myeloma effect: proof of principle. Blood 1996; 87: 1196-1198.
5. Alyea EP, Schlossman RL, Canning C et al. CD8-depleted donor lymphocyte infusions mediate graft-versus-multiple myeloma (MM) effect. Blood 1996; 87 (Suppl. 1): 258a (Abstr. 1021).
6. Collins RH, Shpilberg O, Drobyski WR et al. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997; 15: 433-444.
7. Verdonck LF, Lokhorst HM, Dekker AW et al. Graft-versus-myeloma effect in two cases. Lancet 1996; 347: 800-801.
8. Mehta J, Powles R, Kulkarni S et al. Induction of graft-versus-host disease as immunotherapy of leukemia relapsing after allogeneic transplantation: single-center experience of 32 adult patients. Bone Marrow Transplant 1997; 20: 129-135.
9. Mehta J, Powles R, Treleaven J et al. Outcome of acute leu- kemia relapsing after bone marrow transplantation: utility of second transplants and adoptive immunotherapy. Bone Marrow Transplant 1997; 19: 709-719.
10. Singhal S, Powles R, Treleaven J, Mehta J. Sensitivity of secondary acute myeloid leukemia relapsing after allogeneic bone marrow transplantation to immunotherapy with interferon-α2b. Bone Marrow Transplant 1997; 19: 1151-1153.
11. Munshi NC, Jagannah S, Vesole D et al. Graft vs myeloma effect: thymidine kinase (TK) gene transduced lymphocyte infusion following allogeneic transplantation in myeloma. Blood 1996; 87 (Suppl. 1): 244a (Abstr. 966).
12. Rosler W, Strobel G, Sendler A et al. Relapse of light-chain myeloma after allogeneic bone marrow transplantation: no recurrence of myeloma protein. Bone Marrow Transplant 1996; 17 (Suppl. 1): S71 (Abstr. 329).
13. Bertz H, Burger A, Kunzmann R et al. Adoptive immunotherapy for relapsed multiple myeloma after allogeneic BMT: evidence for a graft-versus-myeloma effect. Leukemia 1997; 11: 281-283.
14. Woodruff RK, Whittle JM, Malpas JS. Solitary plasmacytoma and extramedullary soft-tissue plasmacytoma. Cancer 1979; 43: 2340-2343.
15. Singhal S, Powles R, Kulkarni S et al. Immunotherapy of acute leukemia relapsing after allogeneic bone marrow transplantation: the inseparability of GVHD and graft-vs-leukemia, and the problem of extramedullary relapse. Blood 1997; 90 (Suppl. 1): 547a.
16. Singhal S, Powles R, Treleaven J et al. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Bone Marrow Transplant 1996; 17: 637-641.
17. Tringali S, Vasta S, Scime R et al. Testicular relapse of AML during graft-versus-host disease induced by donor leukocyte infusion. Haematologica 1996; 81: 339-342.
18. Slavin S, Naparstek E, Nagler A et al. Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood 1996; 87: 2195-2204.